Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Nightstar Therapeutics Plc ADR (NITE)

Nightstar Therapeutics Plc ADR (NITE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Nightstar Therapeutics PLC Completion of Acquisition by Biogen

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY RESTRICTED JURISDICTION OR ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS...

NITE : 25.41 (-0.04%)
Biogen Completes Acquisition of Nightstar Therapeutics for Approximately $800 Million

Biogen (Nasdaq: BIIB) today announced that it has completed its acquisition of Nightstar Therapeutics (NST; Nasdaq: NITE), a clinical-stage gene therapy company, which is focused on adeno-associated virus...

NITE : 25.41 (-0.04%)
BIIB : 296.83 (+1.01%)
Nightstar Therapeutics plc Court Approval Received in Connection With Acquisition by Biogen

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY RESTRICTED JURISDICTION OR ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS...

NITE : 25.41 (-0.04%)
Nightstar Therapeutics plc Update to Timetable Relating to the Acquisition by Biogen

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY RESTRICTED JURISDICTION OR ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS...

NITE : 25.41 (-0.04%)
Nightstar Therapeutics PLC Shareholders Approve Scheme of Arrangement for Acquisition By Biogen at General Meeting and Court Meeting Held on 8 May 2019

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY RESTRICTED JURISDICTION OR ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS...

NITE : 25.41 (-0.04%)
Leading Proxy Advisory Firms ISS and Glass Lewis Recommend Nightstar Shareholders Vote "FOR" Proposed Acquisition by Biogen

WALTHAM, Mass. and LONDON, April 26, 2019 (GLOBE NEWSWIRE) -- Nightstar Therapeutics plc ("Nightstar") (NASDAQ: NITE) today announced that both leading independent proxy advisory firms, Institutional...

NITE : 25.41 (-0.04%)
Market Trends Toward New Normal in WageWorks, Maxwell Technologies, Valeritas, NantKwest, Nightstar Therapeutics PLC Sponsored ADR, and Aspen Group -- Emerging Consolidated Expectations, Analyst Ratings

In new independent research reports released early this morning, Capital Review released its latest key findings for all current investors, traders, and shareholders of WageWorks, Inc. (NYSE:WAGE), Maxwell...

WAGE : 51.34 (unch)
MXWL : 4.45 (-0.67%)
VLRX : 1.73 (-1.14%)
NK : 2.88 (+30.91%)
NITE : 25.41 (-0.04%)
ASPU : 7.28 (-3.58%)
Nightstar (NITE) Merger Investigation: Halper Sadeh LLP Announces Investigation into Whether the Sale of Nightstar Therapeutics Plc is Fair to Nightstar Shareholders - NITE

Halper Sadeh LLP, a global investor rights law firm, announces it is investigating whether the sale of Nightstar Therapeutics plc ("Nightstar" or the "Company") (NASDAQ: NITE) to Biogen Inc. ("Biogen")...

NITE : 25.41 (-0.04%)
Recommended Acquisition of Nightstar Therapeutics plc by Tungsten Bidco Limited, a Wholly-Owned Subsidiary of Biogen Switzerland Holdings GmbH; Posting of Scheme Document

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY RESTRICTED JURISDICTION OR ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS...

NITE : 25.41 (-0.04%)
4 Gene Therapy Players Likely to Become Buyout Targets in 2019

Gene therapy continues to be in focus given the recent spate of deals and acquisitions. We highlight four stocks, which have promising gene therapy candidates in their pipeline.

OPHT : 1.39 (-0.71%)
QURE : 73.97 (+7.39%)
ONCE : 110.75 (+0.18%)
RGNX : 43.63 (+3.86%)
SRPT : 132.05 (+31.43%)
NITE : 25.41 (-0.04%)
BOLD : 59.40 (+0.05%)
SLDB : 4.11 (-3.52%)
Health Day Checkup of Medical ETFs: 5 Top Picks

M&A activity, approval of novel drugs and earnings growth in Q1 put healthcare ETFs in a decent spot.

LLY : 121.53 (-0.14%)
BMY : 63.82 (-0.19%)
GSK : 45.98 (+0.11%)
VHT : 188.62 (+0.05%)
BTEC : 37.89 (+0.66%)
BBH : 140.49 (+0.94%)
FBT : 149.57 (+0.69%)
IYH : 211.79 (+0.01%)
XBI : 95.36 (+0.57%)
XLV : 100.88 (-0.07%)
CELG : 108.24 (+0.10%)
ONCE : 110.75 (+0.18%)
NITE : 25.41 (-0.04%)
Health Day Checkup of Medical ETFs: 5 Top Picks

M&A activity, approval of novel drugs and earnings growth in Q1 put healthcare ETFs in a decent spot.

LLY : 121.53 (-0.14%)
BMY : 63.82 (-0.19%)
GSK : 45.98 (+0.11%)
VHT : 188.62 (+0.05%)
BTEC : 37.89 (+0.66%)
BBH : 140.49 (+0.94%)
FBT : 149.57 (+0.69%)
IYH : 211.79 (+0.01%)
XBI : 95.36 (+0.57%)
XLV : 100.88 (-0.07%)
CELG : 108.24 (+0.10%)
ONCE : 110.75 (+0.18%)
NITE : 25.41 (-0.04%)
INVESTOR ALERT: Monteverde & Associates PC is Investigating the Recently Announced Acquisition

Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating:

COTY : 11.08 (-5.06%)
NITE : 25.41 (-0.04%)
HF : 45.60 (+0.26%)
GTXI : 1.20 (unch)
CTL : 13.60 (-1.02%)
BPI : 6.39 (unch)
Biotech Stock Roundup: BIIB to Acquire Nightstar, Other Pipeline News & More

Key highlights of the past week are merger agreements plus regulatory and pipeline developments.

CELG : 108.24 (+0.10%)
BIIB : 296.83 (+1.01%)
REGN : 376.42 (+1.14%)
IMGN : 3.58 (-1.10%)
NITE : 25.41 (-0.04%)
Biogen to Acquire Gene-Therapy Company Nightstar for $800M

Biogen (BIIB) to acquire gene-therapy company, Nightstar Therapeutics to accelerate entry into ophthalmology space.

RHHBY : 38.1600 (-0.73%)
BIIB : 296.83 (+1.01%)
ONCE : 110.75 (+0.18%)
NITE : 25.41 (-0.04%)
Company News For Mar 5, 2019

Companies in the news are; PLCE, BIIB, NITE, ASND and TAK

ASND : 115.19 (-2.10%)
BIIB : 296.83 (+1.01%)
PLCE : 54.11 (-8.02%)
NITE : 25.41 (-0.04%)
TAK : 20.23 (-0.44%)
Nightstar Therapeutics plc reaches agreement to be acquired by Biogen

-- Biogen to acquire Nightstar for US$ 25.50 per share in cash

NITE : 25.41 (-0.04%)

Van Meerten Stock Picks

The 5 Best Large Caps
I wanted to find which Large Caps had the best momentum so I used Barchart to sort the S&P 500 Large Cap Index first by the highest technical buy signals, then by the most frequent number of new highs in the last month.
CCI +0.68 , AIZ -0.29 , SBAC +7.43 , SO +0.05 , WELL -0.46
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar